Abbvie Inc

$216.49
Market Cap 382.79B
ROE -113.3%
Gross Margin 71.9%
Debt/Equity -10.9
Current Ratio 0.8
Revenue QoQ 12.4%
EPS QoQ -0.5%
F-Score 4

About

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
110.77
vs median 32.28
P/B
-60.10
vs median 2.77
ROE
-1.13
vs median 0.12

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics